Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fine, L. G.
Right arrow Articles by Abboud, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fine, L. G.
Right arrow Articles by Abboud, H. E.

Journal of the American Society of Nephrology, Vol 2, 1163-1170, Copyright © 1992 by American Society of Nephrology


EDITORIALS

Evolving role of growth factors in the renal response to acute and chronic disease

LG Fine, MR Hammerman and HE Abboud
Department of Medicine, University College and Middlesex School of Medicine, London, England.

The roles of growth factors in the pathogenesis of various forms of acute and chronic renal disease are largely putative. Nevertheless, there is a growing body of information that links specific growth factors to particular forms of renal injury. In all instances, it is supposed that such associations are not necessarily unique and that multiple cytokines probably interact to determine the pattern of injury or the regenerative response to such injury. Regeneration of tubular epithelium after acute tubular necrosis involves upregulation of the epidermal growth factor (EGF) receptor. Early studies of exogenously administered EGF indicate that the severity and duration of renal failure may be attenuated by this growth factor. Thus far, the observed responses have been limited and the role of EGF as a therapeutic agent requires more study. The mechanism of generation of tubulointerstitial injury in most forms of renal disease is difficult to understand. Early in vitro studies of growth factor production by tubular cells (in the absence of any infiltrating cells) indicate that platelet-derived growth factor produced by the medullary collecting duct is mitogenic for renal medullary fibroblasts, suggesting a paracrine growth system in this region of the kidney. Insulin-like growth factor I has also been shown to be produced by collecting duct cells. Its production is increased by EGF, and its association with certain forms of renal hypertrophy, i.e., diabetes and hypersomatotrophic states, implies its participation in the hypertrophic growth response. Platelet-derived growth factor is a potent mitogen for glomerular mesangial cells, and its production is regulated by a variety of cytokines.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
I. Sinuani, Z. Averbukh, I. Gitelman, M. J. Rapoport, J. Sandbank, M. Albeck, B. Sredni, and J. Weissgarten
Mesangial cells initiate compensatory renal tubular hypertrophy via IL-10-induced TGF-beta secretion: effect of the immunomodulator AS101 on this process
Am J Physiol Renal Physiol, August 1, 2006; 291(2): F384 - F394.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
N. Gill, J. V. Nally Jr, and R. A. Fatica
Renal Failure Secondary to Acute Tubular Necrosis: Epidemiology, Diagnosis, and Management
Chest, October 1, 2005; 128(4): 2847 - 2863.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
U. Haussler, G. von Wichert, R. M. Schmid, F. Keller, and G. Schneider
Epidermal growth factor activates nuclear factor-{kappa}B in human proximal tubule cells
Am J Physiol Renal Physiol, October 1, 2005; 289(4): F808 - F815.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Chaqour, C. Whitbeck, J.-S. Han, E. Macarak, P. Horan, P. Chichester, and R. Levin
Cyr61 and CTGF are molecular markers of bladder wall remodeling after outlet obstruction
Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E765 - E774.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. El Mouedden, G. Laurent, M.-P. Mingeot-Leclercq, H. S. Taper, J. Cumps, and P. M. Tulkens
Apoptosis in Renal Proximal Tubules of Rats Treated with Low Doses of Aminoglycosides
Antimicrob. Agents Chemother., March 1, 2000; 44(3): 665 - 675.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
B. L. RISER, M. DENICHILO, P. CORTES, C. BAKER, J. M. GRONDIN, J. YEE, and R. G. NARINS
Regulation of Connective Tissue Growth Factor Activity in Cultured Rat Mesangial Cells and Its Expression in Experimental Diabetic Glomerulosclerosis
J. Am. Soc. Nephrol., January 1, 2000; 11(1): 25 - 38.
[Abstract] [Full Text]


Home page
LupusHome page
T. Yamamoto, M. Nagase, A. Hishida, and N. Honda
Interstitial Inflammatory and Chronic Tubulointerstitial Lesions in Lupus Nephritis: Comparison with Those in IgA Nephropathy
Lupus, August 1, 1993; 2(4): 261 - 268.
[Abstract] [PDF]


Home page
LupusHome page
T. Yamamoto, M. Nagase, A. Hishida, and N. Honda
Interstitial Inflammatory and Chronic Tubulointerstitial Lesions in Lupus Nephritis: Comparison with Those in IgA Nephropathy
Lupus, January 1, 1993; 2(1_suppl): 261 - 268.
[Abstract] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP